Inquiry Basket
CAS No.: 2254086-60-5
Cat No.: BADC-01601
4.5 
Tusamitamab ravtansine is an antibody-drug conjugate consisting of an anti-carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) antibody conjugated to the potent cytotoxic antitubulin DM4. It has been used in the research of solid tumor treatment.
Structure of 2254086-60-5
* For research and manufacturing use only. We do not sell to patients.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
| Catalog | Product Name | CAS | Inquiry |
|---|---|---|---|
| BADC-02000 | Indatuximab ravtansine | 1238517-16-2 | |
| BADC-01599 | Anetumab ravtansine | 1375258-01-7 | |
| BADC-01616 | Cantuzumab ravtansine | 868747-45-9 |
Tusamitamab ravtansine
Required fields are marked with *
Tusamitamab ravtansine
Required fields are marked with *
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.
